Company
OTCMKTS: BLGO
BioLargo Inc invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. The company accomplishes this by providing the capital, support, and expertise to expedite these disruptive technologies from "cradle" to "maturity". BioLargo monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. The company's patented technologies are all built to be best-in-class solutions to tough technical challenges, and they are backed up by world-class engineering and support services.
82 stories · page 3 of 5
'We are now in a strong cash position, have reliable financing resources, and have retired all but $456,000 of our convertible debt,' says CEO Dennis Calvert
The company has re-designed the Aqueous Electrostatic Concentrator's electrical configuration, improving its operating and maintenance costs
BioLargo Engineering scores big contracts with industrial clients, with a backlog of over $2 million in projects over the next 12-to-18 months
Aside from the debt carried by its partially owned subsidiary Clyra Medical, only SBA loans and fixed-price convertible debt remain on BioLargo's balance sheet
The company said its AEC PFAS water treatment solution produces far less PFAS-laden waste than traditional carbon-based technologies
ONM plans to test-market the product directly with its major solid waste handling customers by packaging it with its popular odor and volatile organic compounds control product CupriDyne Clean
The developer of cutting-edge environmental technologies and a full-service engineering firm said a mutual concern for the environment and the care and conservation of water makes the collaboration between the two companies a "symbiotic mat
Per- and polyfluoroalkyl substances (PFAS) are a class of man-made chemical contaminants found in various products such as cookware and electronics
For its fourth quarter ended December 31, 2020, the California-based company reported revenue of $900,000, a 36% jump, compared to the same quarter in 2019
Archive
Join BioLargo, Phunware and Recruiter.com at the Proactive One2One Investor Forum on January 26
Join BioLargo, Phunware and Recruiter.com at the Proactive One2One Investor Forum on January 26
The pilot will provide real-time data of AOS performance in a municipal wastewater stream
BioLargo believes its two “significant” commercial-scale AOS projects set to start in 2021 will ultimately lead to significant market adoption
The system will treat the wastewater produced by farming operations and convert it to reusable water, saving the farm money and reducing its environmental impact
A percentage of profits from the sales of the company's Clyraguard antimicrobial disinfecting spray is going to support the Nightingale 2030 Resilience Fund
Archive
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
In addition to setting revenue records, BioLargo also significantly reduced its debt obligations during the year
CupriDyne Clean eliminates odor-causing and volatile organic compounds rather than masking them
The company believes the first sales are pending for its two water technologies
The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue
